{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T17:38:02Z","timestamp":1774114682039,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartlungcirc.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.hlc.2016.11.003","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T23:00:49Z","timestamp":1480719649000},"page":"677-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparing the Efficacy of Tadalafil Versus Placebo on Pulmonary Artery Systolic Pressure and Right Ventricular Function in Patients with Beta-Thalassaemia Intermedia"],"prefix":"10.1016","volume":"26","author":[{"given":"Rozita","family":"Jalalian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Akbar","family":"Moghadamnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Tamaddoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Khafri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Iranian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hlc.2016.11.003_bib0140","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1196\/annals.1345.041","article-title":"Pulmonary Hypertension in \u03b2-Thalassemia","volume":"1054","author":"Aessopos","year":"2005","journal-title":"Annals of the New York Academy of Sciences."},{"key":"10.1016\/j.hlc.2016.11.003_bib0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-5-11","article-title":"Review: beta-thalassemia","volume":"5","author":"Galanello","year":"2010","journal-title":"Orphanet J Rare Dis."},{"issue":"1","key":"10.1016\/j.hlc.2016.11.003_bib0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcmd.2006.04.005","article-title":"Thalassemia intermedia: revisited","volume":"37","author":"Taher","year":"2006","journal-title":"Blood Cells, Molecules, and Diseases."},{"issue":"6","key":"10.1016\/j.hlc.2016.11.003_bib0155","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ejim.2011.05.013","article-title":"Risk factors for pulmonary hypertension in patients with \u03b2 thalassemia intermedia","volume":"22","author":"Karimi","year":"2011","journal-title":"European Journal of Internal Medicine."},{"issue":"1","key":"10.1016\/j.hlc.2016.11.003_bib0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1749-6632.2010.05580.x","article-title":"Pulmonary hypertension in thalassemia","volume":"1202","author":"Morris","year":"2010","journal-title":"Annals of the New York Academy of Sciences."},{"issue":"1","key":"10.1016\/j.hlc.2016.11.003_bib0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21693\/1933-088X-6.1.31","article-title":"Pulmonary hypertension in thalassemia: association with hemolysis, arginine metabolism dysregulation and a hypercoaguable state","volume":"6","author":"Morris","year":"2007","journal-title":"Advances in Pulmonary Hypertension."},{"issue":"7","key":"10.1016\/j.hlc.2016.11.003_bib0170","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2174\/156652408786241447","article-title":"Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders","volume":"8","author":"Morris","year":"2008","journal-title":"Current Molecular Medicine."},{"issue":"4","key":"10.1016\/j.hlc.2016.11.003_bib0175","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J."},{"issue":"18","key":"10.1016\/j.hlc.2016.11.003_bib0180","first-page":"1997","article-title":"[Pulmonary arterial hypertension]","volume":"58","author":"Ja\u00efs","year":"2008","journal-title":"Rev Prat."},{"issue":"22","key":"10.1016\/j.hlc.2016.11.003_bib0185","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Gali\u00e8","year":"2009","journal-title":"Circulation."},{"issue":"7","key":"10.1016\/j.hlc.2016.11.003_bib0190","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"Rudski","year":"2010","journal-title":"Journal of the American Society of Echocardiography."},{"issue":"1s1","key":"10.1016\/j.hlc.2016.11.003_bib0195","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"Journal of the American College of Cardiology."},{"issue":"4","key":"10.1016\/j.hlc.2016.11.003_bib0200","doi-asserted-by":"crossref","first-page":"e001103","DOI":"10.1161\/JAHA.114.001103","article-title":"Reliability of Noninvasive Assessment of Systolic Pulmonary Artery Pressure by Doppler Echocardiography Compared to Right Heart Catheterization: Analysis in a Large Patient Population","volume":"3","author":"Greiner","year":"2014","journal-title":"Journal of the American Heart Association."},{"issue":"3","key":"10.1016\/j.hlc.2016.11.003_bib0205","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1378\/chest.08-0904","article-title":"Evaluation of various empirical formulas for estimating mean pulmonary artery pressure by using systolic pulmonary artery pressure in adults","volume":"135","author":"Chemla","year":"2009","journal-title":"CHEST Journal."},{"issue":"11","key":"10.1016\/j.hlc.2016.11.003_bib0210","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.110.988089","article-title":"Pulmonary Hypertension Associated With Hemoglobinopathies Prevalent But Overlooked","volume":"123","author":"Farmakis","year":"2011","journal-title":"Circulation."},{"issue":"9","key":"10.1016\/j.hlc.2016.11.003_bib0215","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3324\/haematol.2012.082065","article-title":"Sildenafil therapy in thalassemia patients with doppler-defined risk for pulmonary hypertension","volume":"98","author":"Morris","year":"2013","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.hlc.2016.11.003_bib0220","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood-2002-04-1171","article-title":"Long-term treatment with oral sildenafil in a thalassemic patient with pulmonary hypertension","volume":"100","author":"Littera","year":"2002","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.hlc.2016.11.003_bib0225","first-page":"452","article-title":"Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies","volume":"90","author":"Derchi","year":"2005","journal-title":"Haematologica."},{"issue":"2","key":"10.1016\/j.hlc.2016.11.003_bib0230","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3324\/haematol.2013.095810","article-title":"Efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up","volume":"99","author":"Derchi","year":"2014","journal-title":"Haematologica."},{"issue":"4","key":"10.1016\/j.hlc.2016.11.003_bib0235","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MPH.0b013e3180437e02","article-title":"Thalassemia in Iran: epidemiology, prevention, and management","volume":"29","author":"Abolghasemi","year":"2007","journal-title":"Journal of Pediatric Hematology\/Oncology."},{"issue":"9","key":"10.1016\/j.hlc.2016.11.003_bib0240","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s12325-009-0064-z","article-title":"Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension","volume":"26","author":"Montani","year":"2009","journal-title":"Advances in Therapy."},{"issue":"2","key":"10.1016\/j.hlc.2016.11.003_bib0245","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1067\/mje.2002.120202","article-title":"Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography","volume":"15","author":"Qui\u00f1ones","year":"2002","journal-title":"Journal of the American Society of Echocardiography."},{"issue":"3","key":"10.1016\/j.hlc.2016.11.003_bib0250","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ijcard.2005.08.051","article-title":"Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension","volume":"108","author":"Affuso","year":"2006","journal-title":"International Journal of Cardiology."},{"issue":"4","key":"10.1016\/j.hlc.2016.11.003_bib0255","first-page":"329","article-title":"Oral tadalafil in pulmonary artery hypertension: a prospective study","volume":"59","author":"Aggarwal","year":"2006","journal-title":"Indian Heart Journal."},{"issue":"1","key":"10.1016\/j.hlc.2016.11.003_bib0260","first-page":"8","article-title":"PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure results of a 1-year, prospective, randomized, placebo-controlled study","volume":"4","author":"Guazzi","year":"2011","journal-title":"Circulation: Heart Failure."},{"issue":"3","key":"10.1016\/j.hlc.2016.11.003_bib0265","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00843.2013","article-title":"Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload","volume":"307","author":"Borgdorff","year":"2014","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology."},{"issue":"1","key":"10.1016\/j.hlc.2016.11.003_bib0270","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCULATIONAHA.106.626226","article-title":"Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure","volume":"115","author":"Lewis","year":"2007","journal-title":"Circulation."}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S144395061631695X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S144395061631695X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T06:24:03Z","timestamp":1568615043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S144395061631695X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S144395061631695X"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2016.11.003","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the Efficacy of Tadalafil Versus Placebo on Pulmonary Artery Systolic Pressure and Right Ventricular Function in Patients with Beta-Thalassaemia Intermedia","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2016.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}